Cloud Medical Doctor Software Corporation's CipherShop Division Has Signed its First Customer to a $1,125,000 Contract

Share Article

Michael DeLaGarza, CEO of Cloud-MD said, "We are excited to announce the first sale of the CipherLoc encryption technology since purchasing CipherShop last year.” According to Michael, “we have spent the last year developing this evolutionary new technology for very specific sales verticals and are now executing on our business plan.”

News Image

Cloud Medical Doctor Software Corporation (Cloud-MD) (OTCQB-NSCT), a leading provider of “Cloud Based” Medical Practice Management Business solutions and a provider of Digital Electronic Security (DES) solutions announced today that it has closed a contract for its first customer to utilize our patented new data-at-rest and data-in-motion technology. All of these advances are based on its CipherLoc technology set.

Mr. Michael DeLaGarza, CEO of Cloud-MD stated, our new customer has a vast amount of experience in the Streaming Audio and Video Industry and will benefit from both current and future CipherShop products and capabilities to safeguard their copywrited material and client accounts from hackers.

As the need for cyber security grows, the pioneers of this sector will become the Gold Standard for the future. This demonstrates the potential sales growth opportunity for CipherShop to become the leader.”

For further information about Cloud Medical Doctor Software Corporation go to, or mdlg(at)cloud-mds(dot)com.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the Company’s SEC filings. These risks and uncertainties could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael DeLaGarza
+1 702-818-9011
Email >

Michael DeLaGarza
Like >
Visit website